32 related articles for article (PubMed ID: 19558602)
1. Neuromodulation for Brain Tumors: Myth or Reality? A Narrative Review.
D'Alessandris QG; Menna G; Izzo A; D'Ercole M; Della Pepa GM; Lauretti L; Pallini R; Olivi A; Montano N
Int J Mol Sci; 2023 Jul; 24(14):. PubMed ID: 37511496
[TBL] [Abstract][Full Text] [Related]
2. RNA Sequencing of Intraoperative Peritumoral Tissues Reveals Potential Pathways Involved in Glioma-Related Seizures.
Kumar K; Dubey V; Zaidi SS; Tripathi M; Siraj F; Sharma MC; Chandra PS; Doddamani R; Dixit AB; Banerjee J
J Mol Neurosci; 2023 Jun; 73(6):437-447. PubMed ID: 37268865
[TBL] [Abstract][Full Text] [Related]
3. Fluoride in the Central Nervous System and Its Potential Influence on the Development and Invasiveness of Brain Tumours-A Research Hypothesis.
Żwierełło W; Maruszewska A; Skórka-Majewicz M; Gutowska I
Int J Mol Sci; 2023 Jan; 24(2):. PubMed ID: 36675073
[TBL] [Abstract][Full Text] [Related]
4. An integrated analysis of the effects of maternal broccoli sprouts exposure on transcriptome and methylome in prevention of offspring mammary cancer.
Arora I; Sharma M; Li S; Crowley M; Crossman DK; Li Y; Tollefsbol TO
PLoS One; 2022; 17(3):e0264858. PubMed ID: 35263365
[TBL] [Abstract][Full Text] [Related]
5. Identification of Immune Cell Infiltration and Immune-Related Genes in the Tumor Microenvironment of Glioblastomas.
Huang S; Song Z; Zhang T; He X; Huang K; Zhang Q; Shen J; Pan J
Front Immunol; 2020; 11():585034. PubMed ID: 33193404
[TBL] [Abstract][Full Text] [Related]
6. Glutamate in cancers: from metabolism to signaling.
Yi H; Talmon G; Wang J
J Biomed Res; 2019 Oct; 34(4):260-270. PubMed ID: 32594024
[TBL] [Abstract][Full Text] [Related]
7. DRG Neurons Promote Perineural Invasion of Endometrial Cancer via GluR2.
Ni T; Huang T; Gu SL; Wang J; Liu Y; Sun X; Wang YD
J Cancer; 2020; 11(9):2518-2528. PubMed ID: 32201522
[No Abstract] [Full Text] [Related]
8. Glutamate Receptors and Glioblastoma Multiforme: An Old "Route" for New Perspectives.
Corsi L; Mescola A; Alessandrini A
Int J Mol Sci; 2019 Apr; 20(7):. PubMed ID: 30978987
[TBL] [Abstract][Full Text] [Related]
9. Sphingosine 1-phosphate (S1P) signaling in glioblastoma multiforme-A systematic review.
Mahajan-Thakur S; Bien-Möller S; Marx S; Schroeder H; Rauch BH
Int J Mol Sci; 2017 Nov; 18(11):. PubMed ID: 29149079
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of PTTG1 expression by microRNA suppresses proliferation and induces apoptosis of malignant glioma cells.
Su X; Chen J; Ni L; Shi W; Shi J; Liu X; Zhang Y; Gong P; Zhu H; Huang Q
Oncol Lett; 2016 Nov; 12(5):3463-3471. PubMed ID: 27900021
[TBL] [Abstract][Full Text] [Related]
11. Hypoxia-inducible factors enhance glutamate signaling in cancer cells.
Hu H; Takano N; Xiang L; Gilkes DM; Luo W; Semenza GL
Oncotarget; 2014 Oct; 5(19):8853-68. PubMed ID: 25326682
[TBL] [Abstract][Full Text] [Related]
12. Simulated annealing based algorithm for identifying mutated driver pathways in cancer.
Li HT; Zhang YL; Zheng CH; Wang HQ
Biomed Res Int; 2014; 2014():375980. PubMed ID: 24982873
[TBL] [Abstract][Full Text] [Related]
13. Glutamate and its receptors in cancer.
Stepulak A; Rola R; Polberg K; Ikonomidou C
J Neural Transm (Vienna); 2014 Aug; 121(8):933-44. PubMed ID: 24610491
[TBL] [Abstract][Full Text] [Related]
14. Synergistic inhibition of survival, proliferation, and migration of U87 cells with a combination of LY341495 and Iressa.
Yelskaya Z; Carrillo V; Dubisz E; Gulzar H; Morgan D; Mahajan SS
PLoS One; 2013; 8(5):e64588. PubMed ID: 23724064
[TBL] [Abstract][Full Text] [Related]
15. Overexpression of calcium-permeable glutamate receptors in glioblastoma derived brain tumor initiating cells.
Oh MC; Kim JM; Safaee M; Kaur G; Sun MZ; Kaur R; Celli A; Mauro TM; Parsa AT
PLoS One; 2012; 7(10):e47846. PubMed ID: 23110111
[TBL] [Abstract][Full Text] [Related]
16. Identification of differentially expressed genes according to chemosensitivity in advanced ovarian serous adenocarcinomas: expression of GRIA2 predicts better survival.
Choi CH; Choi JJ; Park YA; Lee YY; Song SY; Sung CO; Song T; Kim MK; Kim TJ; Lee JW; Kim HJ; Bae DS; Kim BG
Br J Cancer; 2012 Jun; 107(1):91-9. PubMed ID: 22644307
[TBL] [Abstract][Full Text] [Related]
17. Glutamate and the biology of gliomas.
de Groot J; Sontheimer H
Glia; 2011 Aug; 59(8):1181-9. PubMed ID: 21192095
[TBL] [Abstract][Full Text] [Related]
18. Targeting SRC in glioblastoma tumors and brain metastases: rationale and preclinical studies.
Ahluwalia MS; de Groot J; Liu WM; Gladson CL
Cancer Lett; 2010 Dec; 298(2):139-49. PubMed ID: 20947248
[TBL] [Abstract][Full Text] [Related]
19. The GluR2 subunit inhibits proliferation by inactivating Src-MAPK signalling and induces apoptosis by means of caspase 3/6-dependent activation in glioma cells.
Beretta F; Bassani S; Binda E; Verpelli C; Bello L; Galli R; Passafaro M
Eur J Neurosci; 2009 Jul; 30(1):25-34. PubMed ID: 19558602
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
